Bank Of America Corp Hoth Therapeutics, Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.52 - $1.3 $21 - $54	-42 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$0.66 - $1.18 $27 - $49	42 New	42 $0
Q3 2021 Nov 15, 2021	SELL	$1.15 - $1.62 $8 - $11	-7 Closed	0 $0
Q2 2021 Sep 13, 2021	BUY	$1.31 - $2.14 $9 - $14	7 New	7 $0

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.11M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.